BioVaxys Announces BVX-0320 Poster Presentation at ISIRV-WHO Virtual Conference

Corporate Breaking News

Home : BioVaxys Announces BVX-0320 Poster Presentation at ISIRV-WHO Virtual Conference

Oct 08 2021	BioVaxys Announces BVX-0320 Poster Presentation at ISIRV-WHO Virtual Conference
SARS-Cov-2 spike protein vaccine induced strong antibody and T cell responses in murine model VANCOUVER, BC, Oct. 8, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV, FRA:5LB, OTCQB:BVAXF) ("BioVaxys" or "Company"), announced today that a poster highlighting its preclinical data...


Source:https://www.prnewswire.com:443/news-releases/biovaxys-announces-bvx-0320-poster-presentation-at-isirv-who-virtual-conference-301395772.html

Related News
» AUTOCRYPT to Present V2X Security Solution at ITS World Congress 2021 » Oracle, TIM (Telecom Italia) and Noovle Announce Joint Plan to Offer Multicloud Services in Italy